FDA.reportPublic FDA data

METRONIDAZOLE 1% / MUPIROCIN 2%

Manufacturer
Sincerus Florida, LLC
Effective date
2019-05-14
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:28:44

Label at a glance#

ProductMETRONIDAZOLE 1% / MUPIROCIN 2%
Active ingredientMETRONIDAZOLE, MUPIROCIN
Label structure4 sections

Label contents#

Full prescribing information#

Directions for use

INSTRUCTIONS FOR USE SECTION

eded

Sincerus Florida, LLC. Adverse reactions

ADVERSE REACTIONS SECTION

dddd

Active, inactive

COMPONENTS

dd

NDC 72934- 5143-2 METRONIDAZOLE USP 1% / MUPIROCIN USP 2%. Ointment 30gm

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

xx

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
METRONIDAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
MUPIROCIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
f2f8c312-f164-6104-0de4-ec45484840e3Product name220260304
8ffb9b1d-3ed7-ba2e-677e-47d4d134fd55Product name520251024
7f6d14e0-4366-41bc-a4a9-b74c79a20e17Product name120250623
e6d321b0-0e5e-7da6-f043-92b6a91f00a1Product name520250515
e1aac33b-94ae-4ee9-905b-299f7263853bProduct name320250124
16642716-d28a-4f90-8dcb-3921cd8c8109Product name420240516
0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15Product name120240313
0c2e0212-b823-4ce8-611e-853ac2cac1b2Product name420230327
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
a5070875-62bb-61e1-fd46-8f7054197a40Product name820180215
0add4de9-d152-3375-3390-1123dddc5e3dProduct name120140508
33ca0fcc-1011-92dc-50a9-a383683eed1eProduct name120140508
3db2f5c1-f78c-f062-515c-4827e36c2518Product name120140508
53f39d9f-cd3f-04e1-c668-d4580719d57dProduct name120140508
a804000f-b74f-0b5d-d17b-aa767c286ddbProduct name120140508
a91ea265-6e02-c08f-93c8-686d54180529Product name120140508
f74f326b-f453-01a0-e7e7-ce5ea9475503Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72934-5143-22021-01-29C16284748780-1ba0f9c33-44be-a910-e053-dadaa90a0b85METRONIDAZOLE 1% / MUPIROCIN 2%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72934-5143-2METRONIDAZOLE 1% / MUPIROCIN 2%30 g in 1 BOTTLE, PUMPOINTMENT301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72934-5143METRONIDAZOLE 1% / MUPIROCIN 2% OINTMENT [SINCERUS FLORIDA, LLC]1Legacy NDC, 1 package rows20190515_88de7b4e-89f2-7b7d-e053-2a95a90a70b2.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72934-514372934-5143-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
METRONIDAZOLE140QMO216EACTIB
MUPIROCIND0GX863OA5ACTIB

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
88de7b4e-89f3-7b7d-e053-2a95a90a70b288de7b4e-89f2-7b7d-e053-2a95a90a70b22019-05-14Adverse reactionsExact identifier
spl id: 88de7b4e-89f3-7b7d-e053-2a95a90a70b2
spl set id: 88de7b4e-89f2-7b7d-e053-2a95a90a70b2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.